Skip to main content
Hanshang Group Co.,Ltd. logo

Hanshang Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600774 ISIN · CNE000000NC5 Shanghai Stock Exchange Wholesale and retail trade
Filings indexed 1,577 across all filing types
Latest filing 2020-08-19 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 600774

About Hanshang Group Co.,Ltd.

https://www.whhsg.com/

Hanshang Group Co.,Ltd. is a diversified enterprise focused on commercial operations, exhibition services, and healthcare. The company manages a portfolio of large-scale department stores, shopping malls, and specialized retail outlets. Its exhibition segment provides comprehensive venue management and event organization services for international and domestic trade fairs. Hanshang Group has significantly expanded its presence in the healthcare sector through the development and distribution of pharmaceuticals, medical devices, and health-related products. By integrating traditional commercial assets with modern biomedical research and health management services, the group targets a broad consumer base and professional medical markets, emphasizing a strategic transition toward a comprehensive health-oriented business model.

Recent filings

Filing Released Lang Actions
中信建投证券股份有限公司关于上海证券交易所〈关于对汉商集团股份有限公司重大资产购买预案信息披露的问询函〉之核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion regarding a major asset purchase plan by a listed company, Han Shang Group Co., Ltd. It includes extensive disclosures about the transaction, financing arrangements, valuation rationality, goodwill impairment risk measures, and integration plans. The content is focused on a specific transaction, with detailed financial and operational analysis, and includes responses to inquiries from the Shanghai Stock Exchange. This type of document is typical of an Audit Report / Information (AR) related to a major asset acquisition, providing audit and verification opinions on the transaction and related financial matters. It is not an annual or interim report, earnings release, or a simple announcement. The length and depth confirm it is a standalone audit/verification report rather than a brief announcement or presentation. Q1 2020
2020-08-19 Chinese
关于公司重大资产购买预案的修订说明的公告
Capital/Financing Update Classification · 95% confidence The document is titled as an announcement regarding the revision of a major asset purchase plan by the company. It references a previously published major asset purchase plan and details the supplementary disclosures and revisions made to that plan. The document is an announcement about changes to a transaction proposal, not the transaction proposal itself or a full financial report. It is relatively short (1649 characters) and serves to inform shareholders and the market about updates to a previously disclosed plan. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including major asset purchases and related announcements.
2020-08-19 Chinese
重大资产购买预案(修订稿)
Capital/Financing Update Classification · 95% confidence The document is titled "重大资产购买预案(修订稿)" which translates to "Major Asset Purchase Plan (Revised Draft)". It details a significant asset acquisition transaction involving the purchase of 100% equity of a company named 迪康药业 by 汉商集团. The document includes detailed transaction terms, payment arrangements, risk disclosures, decision and approval procedures, and impact analysis on the company. It references regulatory frameworks such as the "重组管理办法" (Regulations on Major Asset Restructuring) and mentions that the transaction constitutes a major asset restructuring under these rules. The document is comprehensive and substantive, containing detailed financial and operational information related to the transaction, not merely an announcement or summary. It is not an annual or interim report, nor a call transcript or earnings release. It is not a proxy statement or voting result announcement. It is a detailed plan and disclosure document related to a major asset purchase, which fits the category of Capital/Financing Update (CAP) as it concerns a significant financing and capital structure event. Therefore, the appropriate classification is CAP with high confidence.
2020-08-19 Chinese
关于上海证券交易所《关于汉商集团股份有限公司重大资产购买预案信息披露的问询函》的回复公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement and response to an inquiry letter from the Shanghai Stock Exchange regarding a major asset purchase plan by 汉商集团股份有限公司 (Hanshang Group Co., Ltd.). It discusses the transaction scheme, financing arrangements, asset valuation, goodwill impairment risk, business and financial integration plans, and other related disclosures. The document includes extensive financial and operational details about the acquisition of 100% equity of a target company, payment schedules, financing sources, risk factors, and independent financial advisor opinions. It is not a full annual or quarterly report, nor a simple announcement or presentation. It is a regulatory disclosure responding to an inquiry about a major asset purchase plan, which fits the category of a Regulatory Filing (RNS) as it is a compliance document providing detailed information but not a formal financial report like a 10-K or IR. The document is lengthy and substantive but is primarily a regulatory response and disclosure rather than a standalone audit report or earnings release. Therefore, the best classification is Regulatory Filings (RNS).
2020-08-19 Chinese
重大资产购买预案摘要(修订稿)
Capital/Financing Update Classification · 95% confidence The document is titled "重大资产购买预案摘要(修订稿)" which translates to "Summary of Major Asset Purchase Plan (Revised Draft)". It details a significant asset acquisition transaction by the company 汉商集团 (Han Shang Group), including transaction parties, pricing, payment arrangements, approvals, risk disclosures, and legal compliance statements. The document references the "重组预案" (restructuring plan) and "重组报告书" (restructuring report), indicating it is a detailed plan related to a major asset purchase, which is a form of significant corporate transaction. The content includes detailed transaction terms, financial arrangements, approvals, and risk factors, consistent with disclosures required for major asset acquisitions. This type of document is characteristic of a Capital/Financing Update (CAP) filing, as it provides comprehensive information about a major financing and asset acquisition event. It is not an Annual Report, Audit Report, or Merger & Acquisition filing in the strict sense, but rather a detailed announcement and plan for a major asset purchase and related financing. The document length (15,000 characters) and detailed content confirm it is the plan itself, not merely an announcement of a report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-08-19 Chinese
关于延期回复上海证券交易所问询函的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 汉商集团股份有限公司 regarding the delay in responding to an inquiry letter from the Shanghai Stock Exchange about a major asset purchase plan. It references a previous inquiry letter and states the company is applying for an extension to reply. The document is short (647 characters) and serves as a regulatory update or announcement rather than a full report or detailed financial disclosure. It does not contain financial statements, audit information, or detailed management discussion. It is not a report publication announcement since it does not mention a report being published or attached. The content fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-08-12 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.